advertisement

---

Rabiolo A 10

Showing records 1 to 10 | Display all abstracts from Rabiolo A

112176 Validating Trend-Based End Points for Neuroprotection Trials in Glaucoma
Montesano G
Translational vision science & technology 2023; 12: 20

---

112762 Risk Factors for Failure in Glaucoma Patients Undergoing Microshunt Implantation
Rabiolo A
American Journal of Ophthalmology 2023; 259: 117-130

---

112176 Validating Trend-Based End Points for Neuroprotection Trials in Glaucoma
Garway-Heath DF
Translational vision science & technology 2023; 12: 20

---

112762 Risk Factors for Failure in Glaucoma Patients Undergoing Microshunt Implantation
Toscani R; Sacchi M
American Journal of Ophthalmology 2023; 259: 117-130

---

112176 Validating Trend-Based End Points for Neuroprotection Trials in Glaucoma
Rabiolo A
Translational vision science & technology 2023; 12: 20

---

112762 Risk Factors for Failure in Glaucoma Patients Undergoing Microshunt Implantation
Destefanis P
American Journal of Ophthalmology 2023; 259: 117-130

---

112176 Validating Trend-Based End Points for Neuroprotection Trials in Glaucoma
De Moraes CG; De Moraes CG; De Moraes CG; De Moraes CG; Ometto G
Translational vision science & technology 2023; 12: 20

---

112762 Risk Factors for Failure in Glaucoma Patients Undergoing Microshunt Implantation
Bettin P; Ciampi C
American Journal of Ophthalmology 2023; 259: 117-130

---

112176 Validating Trend-Based End Points for Neuroprotection Trials in Glaucoma
Crabb DP
Translational vision science & technology 2023; 12: 20

---

112762 Risk Factors for Failure in Glaucoma Patients Undergoing Microshunt Implantation
Clemente A; Cutolo CA; Mercieca K; Iester M; Traverso CE; Di Maita M; Li Calzi G; Nucci P; Bandello F; Triolo G; De Cillà S
American Journal of Ophthalmology 2023; 259: 117-130

---